Switzerland Innovation Park Basel Area offers glimpse into the future
The Switzerland Innovation Park Basel Area offers an insight into its activities. The future home of the Park will be presented in a new showroom. Scientists from the University of Basel will also be presenting their latest developments here.
GRID Campus of Collaoration @Showroom Switzerland Innovation Park Basel Area in Allschwil
From mid-2022, the Switzerland Innovation Park Basel Area will be leasing a total of 6,000m2 in the GRID complex for innovation and commerce, which is currently under construction. The new showroom of the Switzerland Innovation Park Basel Area opening this Thursday will allow visitors to see a model of the new GRID building, the GRID Campus of Collaboration. On 50,000m2, this will provide space for research and innovation in the fields of life sciences, biotech, public health and medtech.
The building was designed by Basel architecture firm Herzog & de Meuron and will be constructed by Senn Resources AG. Both companies have backed the creation of the showroom, alongside Economic Development Baselland and BaselArea.swiss, which operates the Switzerland Innovation Park Basel Area. The Department of Biomedical Engineering (DBE) at the University of Basel has also been involved. It will use the showroom to present its “latest developments in the areas of robotics, laser technology and virtual reality”. In addition, visitors will find information about the work of the Switzerland Innovation Park Basel Area and the startups that will be based there. They will therefore gain a comprehensive insight into the future of the life sciences cluster Allschwil.
The showroom is located on the ground floor of Gewerbestrasse 12 in Allschwil. It is open to all, though registration is required. In future, events will also take place in the showroom.
Share this article
You might also be interested in
Moderna is opening a location in Basel and is advancing the production of the coronavirus vaccine from there. The Swiss government has just signed a supply contract with the US company for 4.5 million doses of the vaccine.Read More
The Japanese conglomerate Yokogawa has established a Swiss subsidiary based at the Switzerland Innovation Park Basel Area. Here, the focus will be on driving forward innovation in the field of biotechnology.Read More
The Werner Siemens Foundation is to invest an additional 12 million Swiss francs in the Miracle project. Researchers at the University of Basel are developing visionary technology for the use of robots in surgery within the framework of this project.Read More
The Basel-based biopharmaceutical company Versameb has successfully closed a seed financing round. Versameb develops therapies on the basis of mRNA sequences and is now seeking to drive forward the clinical development of its platform devised for this.Read More
Two thirds of the value added attributable to the pharmaceutical industry as a whole in Switzerland is generated in the Basel Area, as revealed by an Interpharma report. However, the region also shines in an international comparison. Interpharma CEO René Buholzer regards it as “probably the most productive life sciences location in the world”.Read More
Resistell AG, based in Muttenz in the canton of Basel-Landschaft, has received a grant of up to 2.5 million euros and additional equity capital financing from a European fund with the aim of accelerating innovation. The company is developing the world’s fastest test against antibiotic resistance.Read More